Trials & Approvals
Bluebird Bio Temporarily Suspends Sickle Cell Trials Following Cancer Diagnosis in Two Patients
2021-02-18
FDA Okay of Regeneron’s PD-1 Inhibitor Marks Entry of First Immunotherapy for Advanced Basal Cell Carcinoma
2021-02-12
Taiwan’s TTY Biopharm Pushes for Clinical Trials of its Complex Cancer Generic Drugs in Europe
2021-02-10
COVID-19 News: Singapore, Korea, and China Accelerate Vaccine Approval, Indonesia Devises Detection Strategies
2021-02-06
FDA Approval of Tepotinib Sets Stage for Merck Versus Novartis Showdown in Metastatic NSCLC Space
2021-02-05